Literature DB >> 30367264

Effects of DRD2 splicing-regulatory polymorphism and DRD4 48 bp VNTR on crack cocaine addiction.

Anderson R Stolf1, Renata B Cupertino2, Diana Müller2, Breno Sanvicente-Vieira3, Tatiana Roman2, Eduardo S Vitola4, Eugenio H Grevet4, Lisia von Diemen1, Felix H P Kessler1, Rodrigo Grassi-Oliveira3, Claiton H D Bau1,4, Diego L Rovaris2, Flavio Pechansky1, Jaqueline B Schuch5,6.   

Abstract

There is evidence that dopamine receptors D2 (DRD2) and D4 (DRD4) polymorphisms may influence substance use disorders (SUD) susceptibility both individually and through their influence in the formation of DRD2-DRD4 heteromers. The dopaminergic role on the vulnerability to addiction appears to be influenced by sex. A cross-sectional study with 307 crack cocaine addicts and 770 controls was conducted. The influence of DRD2 rs2283265 and DRD4 48 bp VNTR in exon 3 variants, as well as their interaction on crack cocaine addiction susceptibility and severity were evaluated in women and men separately. An association between the DRD2 T allele and crack cocaine addiction was found in women. In this same group, interaction analysis demonstrated that the presence of DRD2-T allele and concomitant absence of DRD4-7R allele were associated with risk for crack cocaine addiction. No influence of DRD2 and DRD4 variants was observed in men regarding addiction severity. This study reinforces the role of dopaminergic genes in externalizing behaviors, especially the influence of DRD2-DRD4 interaction on SUD. This is the fourth sample that independently associated the DRD2-DRD4 interaction with SUD itself or related disorders. In addition, our findings point out to a potential difference of dopaminergic neurotransmission across sex influencing addiction susceptibility.

Entities:  

Keywords:  Cocaine; Crack; Dependence; Dopamine receptor D2; Dopamine receptor D4; Substance use disorder

Mesh:

Substances:

Year:  2018        PMID: 30367264     DOI: 10.1007/s00702-018-1946-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  62 in total

1.  Psychometric properties of the sixth version of the Addiction Severity Index (ASI-6) in Brazil.

Authors:  Felix Kessler; John Cacciola; Arthur Alterman; Sibele Faller; Maria Lucia Souza-Formigoni; Marcelo Santos Cruz; Sílvia Brasiliano; Flavio Pechansky
Journal:  Braz J Psychiatry       Date:  2012-03       Impact factor: 2.697

2.  DRD2/DRD4 heteromerization may influence genetic susceptibility to alcohol dependence.

Authors:  N R Mota; D L Rovaris; G P Bertuzzi; V Contini; E S Vitola; E H Grevet; T Roman; S M Callegari-Jacques; M H Hutz; C H D Bau
Journal:  Mol Psychiatry       Date:  2012-05-08       Impact factor: 15.992

3.  Association between DRD2/DRD4 interaction and conduct disorder: a potential developmental pathway to alcohol dependence.

Authors:  Nina R Mota; Claiton H D Bau; Tobias Banaschewski; Jan K Buitelaar; Richard P Ebstein; Barbara Franke; Michael Gill; Jonna Kuntsi; Iris Manor; Ana Miranda; Fernando Mulas; Robert D Oades; Herbert Roeyers; Aribert Rothenberger; Joseph A Sergeant; Edmund J Sonuga-Barke; Hans-Christoph Steinhausen; Stephen V Faraone; Philip Asherson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-07-02       Impact factor: 3.568

Review 4.  Addiction and brain reward and antireward pathways.

Authors:  Eliot L Gardner
Journal:  Adv Psychosom Med       Date:  2011-04-19

5.  Association of VNTR polymorphisms in the MAOA promoter and DRD4 exon 3 with heroin dependence in male Chinese addicts.

Authors:  Chia-Chang Chien; Chi-Hung Lin; Yong-Yuan Chang; For-Wey Lung
Journal:  World J Biol Psychiatry       Date:  2010-03       Impact factor: 4.132

Review 6.  Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system.

Authors:  Michelle A Patriquin; Isabelle E Bauer; Jair C Soares; David P Graham; David A Nielsen
Journal:  Psychiatr Genet       Date:  2015-10       Impact factor: 2.458

7.  Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.

Authors:  J K Staley; S Krishnan-Sarin; S Zoghbi; G Tamagnan; M Fujita; J P Seibyl; P K Maciejewski; S O'Malley; R B Innis
Journal:  Synapse       Date:  2001-09-15       Impact factor: 2.562

8.  Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse.

Authors:  Robert A Moyer; Danxin Wang; Audrey C Papp; Ryan M Smith; Linda Duque; Deborah C Mash; Wolfgang Sadee
Journal:  Neuropsychopharmacology       Date:  2010-12-08       Impact factor: 7.853

9.  Dopamine D2 and D4 receptor heteromerization and its allosteric receptor-receptor interactions.

Authors:  Dasiel O Borroto-Escuela; Kathleen Van Craenenbroeck; Wilber Romero-Fernandez; Diego Guidolin; Amina S Woods; Alicia Rivera; Guy Haegeman; Luigi F Agnati; Alexander O Tarakanov; Kjell Fuxe
Journal:  Biochem Biophys Res Commun       Date:  2010-12-22       Impact factor: 3.322

10.  Sex Differences in Synaptic Plasticity: Hormones and Beyond.

Authors:  Molly M Hyer; Linda L Phillips; Gretchen N Neigh
Journal:  Front Mol Neurosci       Date:  2018-07-31       Impact factor: 5.639

View more
  5 in total

Review 1.  Physiological Genomics Plays a Crucial Role in Response to Stressful Life Events, the Development of Aggressive Behaviours, and Post-Traumatic Stress Disorder (PTSD).

Authors:  Thabo Magwai; Khethelo Richman Xulu
Journal:  Genes (Basel)       Date:  2022-02-04       Impact factor: 4.096

2.  Opioid Use Disorder and Alternative mRNA Splicing in Reward Circuitry.

Authors:  Spencer B Huggett; Ami S Ikeda; John E McGeary; Karla R Kaun; Rohan H C Palmer
Journal:  Genes (Basel)       Date:  2022-06-10       Impact factor: 4.141

Review 3.  Prenatal Effects of Nicotine on Obesity Risks: A Narrative Review.

Authors:  Olivia White; Nicole Roeder; Kenneth Blum; Rina D Eiden; Panayotis K Thanos
Journal:  Int J Environ Res Public Health       Date:  2022-08-02       Impact factor: 4.614

4.  The Drosophila brain on cocaine at single-cell resolution.

Authors:  Brandon M Baker; Sneha S Mokashi; Vijay Shankar; Jeffrey S Hatfield; Rachel C Hannah; Trudy F C Mackay; Robert R H Anholt
Journal:  Genome Res       Date:  2021-05-25       Impact factor: 9.043

5.  The Role of Single Nucleotide Polymorphisms of Monoamine Oxidase B, Dopamine D2 Receptor, and DOPA Decarboxylase Receptors Among Patients Treated for Parkinson's Disease.

Authors:  Barbara Zapała; Tomasz Stefura; Monika Piwowar; Sylwia Czekalska; Magdalena Zawada; Maria Hadasik; Bogdan Solnica; Monika Rudzińska-Bar
Journal:  J Mol Neurosci       Date:  2022-01-19       Impact factor: 3.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.